Evogene (EVGN) Equity Ratio (2016 - 2025)

Evogene (EVGN) has disclosed Equity Ratio for 9 consecutive years, with 0.0 as the latest value for Q4 2025.

  • Quarterly Equity Ratio rose 88.76% to 0.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.0 through Dec 2025, up 92.45% year-over-year, with the annual reading at 0.0 for FY2025, 88.76% up from the prior year.
  • Equity Ratio hit 0.0 in Q4 2025 for Evogene, up from 0.04 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.7 in Q4 2021 to a low of 0.04 in Q4 2024.
  • Historically, Equity Ratio has averaged 0.28 across 5 years, with a median of 0.24 in 2023.
  • Biggest five-year swings in Equity Ratio: skyrocketed 366.61% in 2021 and later crashed 115.43% in 2024.
  • Year by year, Equity Ratio stood at 0.7 in 2021, then dropped by 29.23% to 0.5 in 2022, then plummeted by 52.6% to 0.24 in 2023, then crashed by 115.43% to 0.04 in 2024, then skyrocketed by 88.76% to 0.0 in 2025.
  • Business Quant data shows Equity Ratio for EVGN at 0.0 in Q4 2025, 0.04 in Q4 2024, and 0.24 in Q4 2023.